Open AccessAtezolizumab Plus Bevacizumab Standard for Liver Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000737756.35133.32
Subject(s) - bevacizumab , atezolizumab , medicine , sorafenib , regimen , oncology , hepatocellular carcinoma , randomized controlled trial , population , cancer , surgery , chemotherapy , nivolumab , immunotherapy , environmental health